sarcosine has been researched along with n-acetylaspartic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gawlik-Kotelnicka, O; Gmitrowicz, A; Grzelak, P; Kałużyńska, O; Kotlicka-Antczak, M; Podgórski, M; Stefańczyk, L; Strzelecki, D | 1 |
1 trial(s) available for sarcosine and n-acetylaspartic acid
| Article | Year |
|---|---|
Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aspartic Acid; Choline; Creatine; Double-Blind Method; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycine Plasma Membrane Transport Proteins; Hippocampus; Humans; Inositol; Male; Middle Aged; Sarcosine; Schizophrenia; Young Adult | 2015 |